FDA — authorised 17 November 2022
- Application: BLA761183
- Marketing authorisation holder: PROVENTION BIO INC
- Local brand name: TZIELD
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 TZIELD in United States
FDA authorised TZIELD on 17 November 2022
Marketing authorisations
FDA
- Status: approved
TZIELD in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is TZIELD approved in United States?
Yes. FDA authorised it on 17 November 2022; FDA has authorised it.
Who is the marketing authorisation holder for TZIELD in United States?
PROVENTION BIO INC holds the US marketing authorisation.